Financhill
Back

Castle Biosciences Quote, Financials, Valuation and Earnings

Castle Biosciences Price Quote

$29.73
+0.10 (+0.34%)
(Updated: December 11, 2024 at 11:30 AM ET)

Castle Biosciences Key Stats

Sell
33
Castle Biosciences (CSTL) is a Sell

Day range:
$29.21 - $31.01
52-week range:
$16.97 - $35.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.68
P/B ratio:
1.88%

Volume:
275.1K
Avg. volume:
415.2K
1-year change:
46.9%
Market cap:
$829.9M
Revenue:
$219.8M
EPS:
$0.21

How Much Does Castle Biosciences Make?

Is Castle Biosciences Growing As A Company?

  • What Is Castle Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Castle Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Castle Biosciences Stock Price Performance

What Is Castle Biosciences 52-Week High & Low?

Castle Biosciences Price To Free Cash Flow

Is It Risky To Buy Castle Biosciences?

  • How Much Debt Does Castle Biosciences Have?
    Total long term debt quarterly is $10M
  • How Much Cash Does Castle Biosciences Have?
    Cash and short term investments quarterly total is $279.8M
  • What Is Castle Biosciences’s Book Value Per Share?
    Book value per share is 15.77

Is Castle Biosciences Cash Flow Positive?

  • What Is CSTL Cash Flow From Operations?
    Cash flow from operations (TTM) is $59.1M
  • What Is Castle Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.2M
  • What Is Castle Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$63.6M

Castle Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CSTL return on invested capital is 1.46%
  • What Is Castle Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 1.29%
  • What Is CSTL Return On Equity?
    ROE is a measure of profitability and is 1.49%

Castle Biosciences Earnings Date & Stock Price

Castle Biosciences Competitors

Castle Biosciences Dividend Yield

Castle Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 966.67%
Revenue: 39.5% 8.6%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 41.56
Upside from Last Price: 40.25%

Major Shareholders

  • How many CSTL shares are owned by institutional investors?
    39.8M CSTL shares are owned by institutional investors
  • How many CSTL shares are owned by insiders?
    635.4K CSTL shares are owned by insiders